Enclomiphene vs Clomid: The Isomer Decision for PCT and HPTA Recovery

Last updated: April 2026. Written by the Elite Bio Supply research team. Every product is sourced from verified pharmaceutical manufacturers, blister packed with batch identification, and inspected before dispatch.

Enclomiphene and clomiphene (Clomid) are not different drugs. They are the same molecule, just isolated differently. Clomiphene citrate is a 62/38 mixture of enclomiphene (the trans isomer) and zuclomiphene (the cis isomer). Enclomiphene is the active isomer for HPTA recovery. Zuclomiphene is responsible for most of the mood and vision side effects. Once a researcher understands that, the “enclomiphene vs clomid” question becomes a question about whether to keep the 38 percent of the molecule that causes most of the problems. This page covers the mechanism, the dosage equivalence, the side effect profile, the literature depth on each, and where EBS fits in the comparison.

Elite Bio Supply sells both clomiphene citrate (100 mg, 30 tablets) and enclomiphene citrate (50 mg, 5 tablets) as research compounds. We have no commercial reason to push you toward one or the other. The honest read is below.

Quick answer (if you only read one paragraph)

Clomiphene citrate is a 62/38 mixture of enclomiphene and zuclomiphene. Enclomiphene is the active isomer driving HPTA recovery. Zuclomiphene is a weak estrogen agonist with a long half life of approximately 30 days that contributes most of the mood shifts and visual disturbances reported on Clomid. Pure enclomiphene at 12.5 to 25 mg daily has been reported to produce LH and FSH increases comparable to clomiphene at 50 mg daily, with a cleaner side effect profile. Clomid has 60 plus years of clinical data and is significantly cheaper. Enclomiphene has 15 plus years of dedicated clinical data, costs more per dose, and is the cleaner option for researchers sensitive to mood or vision side effects, or for long term HPTA monotherapy. For a 4 week PCT, both work. For long term hypogonadal protocols (6 to 12 months), enclomiphene is increasingly the default because the zuclomiphene buildup over time becomes the dominant side effect driver.

Table of contents

1. The same molecule, almost
2. Mechanism: where they are identical, where they diverge
3. Side by side comparison
4. Dosage equivalence: 50 mg Clomid equals what dose of enclomiphene
5. Side effects: the zuclomiphene contribution
6. Clinical data: depth vs breadth
7. PCT use: which one and why
8. Long term hypogonadism use (clomiphene monotherapy)
9. Cost and availability in Canada
10. What researchers are running
11. Where EBS fits
12. FAQ

---

The same molecule, almost

Clomiphene citrate, marketed as Clomid since 1967, is a triphenylethylene SERM made up of two stereoisomers in a 62 to 38 ratio. The two isomers were not separated commercially for the first four decades of clomiphene’s clinical use because the manufacturing process produced both, the regulatory approval was for the mixture, and the pharmacology of the individual isomers was not fully characterised until the 2000s.

Enclomiphene (the trans isomer, sometimes called the E isomer): a pure estrogen receptor antagonist at the hypothalamus. Drives the LH and FSH increase that restarts testicular testosterone production. Half life approximately 5 to 7 days. No meaningful estrogen agonist activity at the doses used clinically.

Zuclomiphene (the cis isomer, sometimes called the Z isomer): a weak estrogen receptor agonist with a long half life of approximately 30 days. Produces some HPTA effects through partial antagonism but is mostly responsible for the mood, vision, and emotional blunting side effects reported on Clomid. The 30 day half life means zuclomiphene accumulates over the course of a 4 week PCT or a multi month monotherapy protocol, and the side effect profile generally worsens over time.

The pharmaceutical separation of enclomiphene was driven by clinical interest in male hypogonadism and the goal of preserving the LH and FSH benefit while removing the side effect contribution from zuclomiphene. Enclomiphene citrate became commercially available as a separate compound in the 2010s.

Mechanism: where they are identical, where they diverge

Both compounds drive the same upstream signal: blocking estrogen feedback at the hypothalamus, which causes increased GnRH release, which triggers LH and FSH release from the pituitary, which signals the testes to resume testosterone production. The cascade is the same.

The difference is what comes with the package.

Pure enclomiphene delivers the antagonist signal cleanly. No agonist activity at peripheral tissues. No long half life isomer to accumulate. No partial estrogen agonism at the breast or uterus.

Clomiphene citrate delivers the same antagonist signal from the enclomiphene fraction, plus zuclomiphene’s weak partial agonism, plus the long half life of zuclomiphene that means the molecule is present at meaningful concentrations weeks after the last dose. The HPTA recovery effect is similar in magnitude. The peripheral effects and the side effect profile are not.

This is why the dosage comparison in published research generally uses 12.5 to 25 mg enclomiphene against 50 mg clomiphene: the enclomiphene fraction in 50 mg of clomiphene is 31 mg, but the active fraction over the dosing interval (accounting for accumulation) is closer to 12.5 to 25 mg of pure enclomiphene equivalent. The zuclomiphene fraction is what produces the additional dose dependent side effects.

Side by side comparison

Feature	Clomid (clomiphene citrate)	Enclomiphene citrate
Composition	62% enclomiphene, 38% zuclomiphene	100% enclomiphene
Half life	Enclomiphene 5 to 7 days, zuclomiphene approximately 30 days	5 to 7 days
Standard PCT dose	25 to 50 mg daily	12.5 to 25 mg daily
Site of primary action	Hypothalamus	Hypothalamus
Estrogen agonist activity	Yes (zuclomiphene fraction)	None at clinical doses
Mood side effects	Moderate to high	Low to moderate
Vision side effects	Possible at high dose	Rare
Lipid effects	Neutral to mildly positive	Neutral to mildly positive
Accumulation over time	Yes (zuclomiphene)	Minimal
Clinical data depth	60+ years	15+ years
Cost per dose	Lower	Higher
First regulatory approval	1967	2010s

Dosage equivalence: 50 mg Clomid equals what dose of enclomiphene

The dosage equivalence reported in clinical and bodybuilding literature:

Clomiphene dose	Enclomiphene equivalent
25 mg daily	12.5 mg daily
50 mg daily	12.5 to 25 mg daily
100 mg daily	25 mg daily

The relationship is not perfectly linear because the zuclomiphene buildup on clomiphene affects the side effect curve more than the LH and FSH curve. At low doses, the two compounds produce similar HPTA effects. At high doses, the side effect divergence widens significantly because zuclomiphene accumulation drives most of the dose dependent toxicity.

A typical 4 week PCT protocol on enclomiphene:

Week	Enclomiphene
Week 1	25 mg daily
Week 2	25 mg daily
Week 3	12.5 mg daily
Week 4	12.5 mg daily

Versus the equivalent 4 week protocol on clomiphene:

Week	Clomiphene
Week 1	50 mg daily
Week 2	50 mg daily
Week 3	25 mg daily
Week 4	25 mg daily

Both stacks pair with Nolvadex 20 mg daily across the 4 weeks for the breast tissue protection slot. See the Clomid vs Nolvadex for PCT page for the full stack rationale.

Side effects: the zuclomiphene contribution

Both compounds share a baseline SERM side effect profile: hot flashes, reduced libido during the protocol, occasional headache, mild GI effects in some users. The divergence is in the additional side effects that zuclomiphene contributes on Clomid.

Side effects more common on Clomid (clomiphene) than on pure enclomiphene:
– Mood shifts, irritability, emotional blunting (driven mostly by zuclomiphene)
– Visual disturbances at moderate to high dose: blurring, floaters, light sensitivity
– Persistence of side effects after discontinuation (zuclomiphene’s 30 day half life)
– Worsening of side effects over the course of a multi week protocol due to zuclomiphene accumulation

Side effects more or less equivalent between the two:
– Hot flashes
– Reduced libido during protocol
– Headache
– Mild liver enzyme elevation in extended high dose protocols

The practical translation: a researcher on a single 4 week PCT may not notice a meaningful side effect difference between the two because zuclomiphene has not yet accumulated to its steady state concentration. A researcher on a 12 week clomiphene monotherapy protocol will almost certainly notice the difference, which is why long term hypogonadism protocols have shifted heavily toward enclomiphene over the past 5 years.

Full side effect review on the Clomid PCT side effects page.

Clinical data: depth vs breadth

This is where Clomid still has an advantage that enclomiphene cannot match.

Clomid clinical data:
– 60 plus years of regulatory and clinical use
– Approved for female infertility in dozens of countries since 1967
– Used off label for male hypogonadism for at least 40 years (Moskovic 2012, Katz 2012)
– Long term safety data covering decades of use across millions of patients
– Generic, multiple manufacturers, low cost, broadly available

Enclomiphene clinical data:
– Approximately 15 years of dedicated research as a separated isomer
– Phase II and III trials in male secondary hypogonadism (Wiehle 2013, Wiehle 2014, Earl 2019)
– Pharmacokinetic and pharmacodynamic profile fully characterised
– Demonstrated to maintain spermatogenesis in hypogonadal men, unlike topical testosterone (Kim 2016)
– Not yet approved as a stand alone pharmaceutical in most jurisdictions; sold as a research compound

For a researcher choosing between the two on the basis of literature depth, Clomid wins. For a researcher choosing on the basis of side effect profile and long term tolerance, enclomiphene wins. Most current PCT and hypogonadism research treats them as alternatives with overlapping evidence bases rather than as competitors.

PCT use: which one and why

For a 4 week PCT after a moderate cycle, both compounds work and the literature supports both. The decision hinges on two questions.

How sensitive is the researcher to zuclomiphene side effects? Researchers with prior clomiphene exposure who experienced mood shifts or vision disturbances are likely to do better on enclomiphene. Researchers who have not used clomiphene before and have no specific sensitivity profile can start on either, with the option to switch if side effects become a problem.

What is the cycle profile? For very short or mild cycles where the protocol may only run 2 to 3 weeks, clomiphene’s lower cost is an advantage and zuclomiphene accumulation is minimal at that duration. For longer or heavier cycles where the PCT may run 4 to 6 weeks, enclomiphene’s cleaner profile becomes more relevant.

The decision is usually not “Clomid bad, enclomiphene good.” It is “Clomid is the cheaper option that has worked clinically for decades, enclomiphene is the cleaner option for sensitive researchers and longer protocols, and either one paired with Nolvadex covers the standard PCT use case.”

Long term hypogonadism use (clomiphene monotherapy)

Outside of PCT, clomiphene and enclomiphene are both used as long term monotherapy for male hypogonadism, particularly in researchers who want to preserve fertility and avoid TRT. The protocols here are different from PCT.

Clomiphene monotherapy: typically 25 mg every other day or 12.5 to 25 mg daily for 6 to 12 months or longer. Regular bloodwork required (testosterone, estradiol, LH, FSH, lipids). The zuclomiphene accumulation becomes the dominant side effect driver over multi month protocols.

Enclomiphene monotherapy: typically 12.5 to 25 mg daily, occasionally pulsed (5 days on, 2 days off). Same bloodwork cadence. Significantly cleaner side effect profile over long protocols because there is no long half life isomer to accumulate.

For long term hypogonadism management, enclomiphene has become the increasingly common choice, particularly among urology practices that prescribe SERM monotherapy for fertility preservation. The cost premium of enclomiphene matters less when the protocol runs 12 months than when it runs 4 weeks.

Cost and availability in Canada

In the Canadian research compound market:

Clomiphene citrate is broadly available, cheaper per dose, and has been in the catalogue of every major Canadian research supplier for years. The supply chain is mature.

Enclomiphene citrate is a newer compound with a shorter Canadian supply history and a higher per dose cost. Catalogue availability is narrower. Pricing reflects both the smaller scale of production and the active patent and regulatory landscape around enclomiphene as a pharmaceutical.

EBS pricing as of April 2026:
– Clomiphene citrate 100 mg, 30 tablets: $50 CAD on sale ($100 CAD regular)
– Enclomiphene citrate 50 mg, 5 tablets: $35 CAD on sale ($70 CAD regular)

The per milligram cost is higher on enclomiphene, which is consistent with global market pricing.

What researchers are running

The pattern across r/steroids, r/PEDs, r/Hypogonadism, and the major Canadian research forums:

For 4 week PCT: “I ran Clomid on the last cycle, switching to enclo this time, mood shifts were bad.” The shift from clomiphene to enclomiphene for sensitive researchers is the most common pattern. Researchers who tolerated Clomid well often stick with it because the cost difference is real over multiple PCTs per year.

For long term monotherapy: “Six months in on enclo, mood and libido are better than they were on Clomid at month two.” The long term tolerance gap between the two compounds is consistently reported as larger than the short term gap.

For first time users: “Starting my first PCT, debating Clomid vs enclo.” First time researchers often default to clomiphene on cost grounds and switch to enclomiphene later if side effects become an issue. This is a reasonable strategy because the side effect profile is impossible to predict in an individual researcher without trying it.

The minority view: “Clomid worked fine, enclo is overpriced for what it does.” Some researchers tolerate clomiphene without meaningful side effects and see the price premium for enclomiphene as not worth it. This is a defensible position for researchers who run short PCT protocols and have no zuclomiphene sensitivity.

Where EBS fits

Elite Bio Supply sells both compounds. We do not have a commercial reason to push you toward one over the other.

Clomiphene citrate 100 mg, 30 tablets: $50 CAD on sale. Best value per dose for short PCT protocols. The compound with the deepest clinical literature behind it.

Enclomiphene citrate 50 mg, 5 tablets: $35 CAD on sale. Cleaner side effect profile for sensitive researchers and long term protocols. Smaller pack size reflects the typical lower daily dose.

What EBS does on both:
– Verified pharmaceutical sourcing. Sealed, labelled products from verified pharmaceutical manufacturers. Blister packed with batch identification. Every order inspected before dispatch.
– Canadian owned and shipped. Canada Post domestic, 2 to 5 business days. No CBSA exposure.
– CAD pricing. No FX surprise at checkout.
– Reship on seizure. If Canada Post returns or detains a package due to inspection, we reship once at no cost.
– Interac e Transfer and crypto. Bank to bank Canadian payment plus BTC, ETH, USDT, and over 350 cryptocurrencies through NOWPayments.

FAQ

Is enclomiphene better than Clomid?
Not strictly better, but cleaner. Enclomiphene is the active isomer of clomiphene without the zuclomiphene fraction that drives most of the mood and vision side effects. For sensitive researchers and long term protocols, enclomiphene is generally preferred. For short PCT protocols on a budget, Clomid is still a defensible choice.

What is the enclomiphene equivalent of 50 mg Clomid?
12.5 to 25 mg daily of pure enclomiphene produces LH and FSH increases comparable to 50 mg Clomid, based on Wiehle 2013 and Earl 2019. The relationship is not perfectly linear but this is the published equivalence range.

Why does enclomiphene cost more than Clomid?
Smaller scale of production, shorter supply history, and active patent and regulatory landscape around enclomiphene as a separated pharmaceutical. The cost premium is real but reasonable given the cleaner side effect profile.

Can I use enclomiphene instead of Clomid for PCT?
Yes. The HPTA recovery effect is similar at the equivalent dose. Most modern PCT protocols are moving toward enclomiphene plus tamoxifen, replacing the older Clomid plus tamoxifen stack.

Does enclomiphene have the same side effects as Clomid?
The baseline SERM side effects (hot flashes, reduced libido during protocol) are similar. The mood shifts, vision disturbances, and emotional blunting reported on Clomid are largely driven by zuclomiphene and are significantly less common on pure enclomiphene.

Is Clomid still worth using if enclomiphene is cleaner?
Yes for several scenarios: short PCT protocols, researchers without specific zuclomiphene sensitivity, budget constrained protocols, and protocols where the literature depth on Clomid (60+ years) matters more than the side effect profile.

Can I run enclomiphene long term?
Enclomiphene is the increasingly common choice for long term hypogonadal monotherapy (6 to 12 months or longer) precisely because it does not accumulate the way zuclomiphene does. Bloodwork cadence is the same as for clomiphene monotherapy.

Does EBS sell both?
Yes. Clomiphene citrate 100 mg, 30 tablets at $50 CAD on sale. Enclomiphene citrate 50 mg, 5 tablets at $35 CAD on sale. Both sealed and labelled from verified pharmaceutical manufacturers with batch identification.

Where can I buy enclomiphene in Canada?
EBS ships enclomiphene citrate 50 mg, 5 tablets domestically across Canada. Sealed and labelled from a verified pharmaceutical manufacturer with batch identification. Canada Post 2 to 5 day shipping with seizure reship.

Should a first time user start on Clomid or enclomiphene?
A reasonable default is to start on Clomid because the cost is lower and the literature is deeper, then switch to enclomiphene if mood or vision side effects become a problem. Researchers with prior knowledge of zuclomiphene sensitivity should start directly on enclomiphene.

---

References

---

Research compound disclaimer

The compounds referenced on this page are sold by Elite Bio Supply as research compounds intended for in vitro and laboratory research use only. They are not for human or veterinary consumption, not pharmaceuticals, not dietary supplements, and have no DIN. Nothing on this page constitutes medical advice. Always consult a qualified healthcare provider about medical decisions.

---

Related reading

• Clomid PCT: The Complete Canadian Research Guide
• Clomid PCT dosage (25 mg, 50 mg, 100 mg)
• Clomid PCT protocol: 4 week and 6 week schedules
• Clomid PCT side effects: full review
• Clomid vs Nolvadex for PCT
• How EBS verifies product quality
• Shop: Clomiphene Citrate 100 mg, 30 tablets
• Shop: Enclomiphene Citrate 50 mg, 5 tablets